Analysis of gene expression in early-stage ovarian cancer.
GSE8842_eset.Rd
Gene expression profile was analyzed in 68 stage I and 15 borderline ovarian cancers to determine if different clinical features of stage I ovarian cancer such as histotype, grade, and survival are related to differential gene expression.Tumors were obtained directly at surgery and immediately frozen in liquid nitrogen until analysis. Glass arrays containing 16,000 genes were used in a dual-color assay labeling protocol.Unsupervised analysis identified eight major patient partitions, one of which was statistically associated to overall survival, grading, and histotype and another with grading and histotype. Supervised analysis allowed detection of gene profiles clearly associated to histotype or to degree of differentiation. No difference was found between borderline and grade 1 tumors. As to recurrence, a subset of genes able to differentiate relapsers from nonrelapsers was identified. Among these, cyclin E and minichromosome maintenance protein 5 were found particularly relevant, as their expression was inversely correlated to progression-free survival (P = 0.00033 and 0.017, respectively).Specific molecular signatures define different histotypes and prognosis of stage I ovarian cancer. Mucinous and clear cells histotypes can be distinguished from the others regardless of tumor grade. Cyclin E and minichromosome maintenance protein 5, whose expression was found previously to be related to a bad prognosis of advanced ovarian cancer, appear to be potential prognostic markers in stage I ovarian cancer too, independent of other pathologic and clinical variables.
Usage
data( GSE8842_eset )
Format
experimentData(eset):
Experiment data
Experimenter name: Marchini S, Mariani P, Chiorino G, Marrazzo E, Bonomi R, Fruscio R, Clivio L, Garbi A, Torri V, Cinquini M, Dell'Anna T, Apolone G, Broggini M, D'Incalci M.Analysis of gene expression in early-stage ovarian cancer. Clin Cancer Res. 2008 Dec 1; 14(23):7850-60.
Laboratory: Marchini, D'Incalci 2008
Contact information:
Title: Analysis of gene expression in early-stage ovarian cancer.
URL:
PMIDs: 19047114
Abstract: A 225 word abstract is available. Use 'abstract' method.
Information is available on: preprocessing
notes:
platform_title:
Agilent Human 1 cDNA Microarray (G4100A)
platform_shorttitle:
Agilent G4100A cDNA
platform_summary:
hgug4100a
platform_manufacturer:
Agilent
platform_distribution:
custom-commerical
platform_accession:
GPL5689
platform_technology:
spotted DNA/cDNA
Preprocessing: default
featureData(eset):
An object of class 'AnnotatedDataFrame'
featureNames: A2M AADAC ... ZYX (6536 total)
varLabels: probeset gene
varMetadata: labelDescription
Details
assayData: 6536 features, 83 samples
Platform type: hgug4100a
Overall survival time-to-event summary (in years):
Call: survfit(formula = Surv(time, cens) ~ -1)
records n.max n.start events median 0.95LCL 0.95UCL
83 83 83 15 NA 12 NA
---------------------------
Available sample meta-data:
---------------------------
alt_sample_name:
Length Class Mode
83 character character
sample_type:
borderline tumor
15 68
histological_type:
Length Class Mode
83 character character
primarysite:
ov
83
summarygrade:
high low NA's
35 33 15
summarystage:
early
83
tumorstage:
1
83
substage:
a b c
25 5 53
grade:
1 2 3 NA's
13 20 35 15
age_at_initial_pathologic_diagnosis:
Min. 1st Qu. Median Mean 3rd Qu. Max.
21.00 43.00 50.00 51.25 61.00 87.00
recurrence_status:
norecurrence recurrence
62 21
days_to_death:
Min. 1st Qu. Median Mean 3rd Qu. Max.
0 1192 2248 2273 3048 5824
vital_status:
deceased living
15 68
uncurated_author_metadata:
Length Class Mode
83 character character